Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Anteris Technologies Ltd (AVR.AX)

Anteris Technologies Ltd (AVR.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Anteris Technologies Ltd 9 Sherwood Road Level 3, Suite 302, Toowong Tower Toowong QLD 4066 AUS

https://www.anteristech.com P: +61 731523200

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.

Key Statistics

Overview:

Market Capitalization, $K 861,742
Shares Outstanding, K 96,850
% of Institutional Shareholders 0.70%

Financials:

Annual Sales, $ 2,703 K
Annual Net Income, $ -76,291 K
Last Quarter Sales, $ 429 K
Last Quarter Net Income, $ -22,244 K

Growth:

1-Year Return -17.73%
3-Year Return -59.58%
5-Year Return -6.38%
5-Year Revenue Growth -25.72%

Per-Share Information:

Most Recent Earnings -0.62 on 11/12/25
Next Earnings Date N/A
Earnings Per Share ttm -2.60
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 03/02/20

AVR.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -2,280.10%
Return-on-Assets % -442.06%
Profit Margin % -2,822.46%
Debt/Equity 0.01
Price/Sales 96.37
Price/Book 164.09
Book Value/Share 0.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar